- Open Access
Functional dissection of the alphavirus capsid protease: sequence requirements for activity
© Thomas et al; licensee BioMed Central Ltd. 2010
- Received: 5 November 2010
- Accepted: 18 November 2010
- Published: 18 November 2010
The alphavirus capsid is multifunctional and plays a key role in the viral life cycle. The nucleocapsid domain is released by the self-cleavage activity of the serine protease domain within the capsid. All alphaviruses analyzed to date show this autocatalytic cleavage. Here we have analyzed the sequence requirements for the cleavage activity of Chikungunya virus capsid protease of genus alphavirus.
Amongst alphaviruses, the C-terminal amino acid tryptophan (W261) is conserved and found to be important for the cleavage. Mutating tryptophan to alanine (W261A) completely inactivated the protease. Other amino acids near W261 were not having any effect on the activity of this protease. However, serine protease inhibitor AEBSF did not inhibit the activity. Through error-prone PCR we found that isoleucine 227 is important for the effective activity. The loss of activity was analyzed further by molecular modelling and comparison of WT and mutant structures. It was found that lysine introduced at position 227 is spatially very close to the catalytic triad and may disrupt electrostatic interactions in the catalytic site and thus inactivate the enzyme. We are also examining other sequence requirements for this protease activity.
We analyzed various amino acid sequence requirements for the activity of ChikV capsid protease and found that amino acids outside the catalytic triads are important for the activity.
- Capsid Protein
- Catalytic Triad
- Protease Domain
- Semliki Forest Virus
- Sindbis Virus
Alpha viruses are spherical, enveloped, positive-sense ssRNA viruses responsible for a considerable number of human and animal diseases. Alphavirus members include Chikungunya virus (ChikV), Sindbis virus, Semliki Forest virus (SFV), the Western, Eastern and Venezuelan equine encephalitis viruses, and the Ross River virus. Some alphaviruses can cause arthritic diseases and encephalitis in humans and animals and continue to be a worldwide threat. The viruses are transmitted by blood-sucking arthropods, and replicate in both, arthropod and vertebrate hosts . Among alphaviruses, ChikV is considered a re-emerging virus in the family of Togaviridae. ChikV infection produces an illness in humans that is characterized by fever, headache, nausea, vomiting, myalgia, rash, arthralgia, encephalitis, and lethal hepatitis .
The alphaviral single-stranded RNA genome is packaged into a nucleocapsid made up of 240 copies of the basic capsid protein . The nucleocapsid is surrounded by a lipid bilayer containing two integral glycosylated membrane proteins (E2 and E1) and a small peripheral protein E3. The alphavirus capsid is multifunctional and plays a key role in the viral life cycle. It is made up of two domains, the unstructured, RNA binding N-terminal segment (residues 1-118) and the C-terminal globular protease domain (residues 119-267) . The serine protease domain consists of a β-barrel motif with a typical serine-histidine-aspartic acid catalytic triad with the active site interspersed between two subdomains [5, 6].
The first cleavage event in SFV is executed by the serine protease domain of the capsid protein. Cleavage occurs between tryptophan 267 and serine 268 of the polyprotein and releases the capsid protein. After the autoproteolytic cleavage, the free carboxylic group of W267 interacts with the catalytic triad (H145, D167 and S219) and thus leads to self inactivation. Even though the capsid protease is a chymotrypsin like protease, there is an important structural difference to this protease family. The viral protease lacks the C-terminal α-helix present in chymotrypsin and instead forms two short β-strands. These β-strands lead to bending of the C-terminus towards the centre of the capsid protein that allows the last W267 side-chain to reach the active site for auto cleavage to occur .
The capsid protease of alphaviruses is well studied. The proteolytic cleavage has been shown to be critical for the life cycle of alphaviruses. A change of S219 to arginine in a conserved tetrapeptide of the catalytic triad, G-D-S(219)-G, of SFV completely abolished in vitro cleavage of the capsid protease . All alphaviruses analyzed to date show this autocatalytical cleavage between tryptophan and serine residues. In the SFV capsid, substitution of W267 for three other residues, A, F and R  showed that the wild-type W is a better substrate than F for the autoprotease, and that only the W residue allowed efficient viral growth. In vitro studies have shown that C-terminal deletion variants of SFV capsid protease and the mutant W267A catalyzed the hydrolysis of ester derivatives of aromatic amino acids (aa) .
Most studies on the alphaviral capsid protease have been performed with SFV. We have analyzed for the first time the sequence requirements for the cleavage activity of ChikV capsid protease of genus alphavirus. We also show further evidence about the role of tryptophan 261 in ChikV. Autoproteolytic cleavage of the ChikV capsid is abolished completely upon substituting tryptophan with alanine. Through error-prone PCR we found that isoleucine 227 is also important for the efficient activity of the protease.
We next analyzed if a deletion at the C-terminus retained its protease activity. As shown in Figure 2, lane 2, a deletion of 46 aa from the C-terminus completely abolished the protease activity. While E256, G257 and E259 in ChikV capsid are conserved among alphavirus capsid, the aa in positions 258 and 260 seem to vary specifically between virus species (Figure 1). Crystal structures of SFV and Sindbis virus also show the importance of aa in the C-terminus to anchor the tryptophan residue into the active site [4, 5]. Thus, we set out to analyze the influence of the C-terminal aa sequence for the activity of the ChikV capsid protease. As expected, mutating tryptophan in the 261 position to alanine (W261A) completely inactivated the protease (Figure 2, lane 9). We then analyzed if aa near tryptophan in the cleavage site of the protease domain will have any effect on enzyme activity. As shown in the Western blot (Figure 2, lanes 3-6 and 10-11), mutations at these sites were not found to have any effect on the protease activity. Even the substitution of E256 conserved in all alphaviruses to alanine did not have any effect on the activity of the capsid protease.
To identify additional motifs important for the protease activity, we performed an error-prone PCR to introduce mutations. We obtained and analyzed mutants with substitutions of P61L, Q86R, A207V, or I227K. Mutants P61L, Q86R, and A207V of the capsid did not have any effect on the activity of the protease (data not shown). However, an exchange of isoleucine 227 to lysine completely inactivated the protease activity (Figure 2, lane 7).
The cleavage specificity of alphaviral capsid proteases has been characterized partially for SFV and Sindbis virus [4, 7]. The main determinants identified for site-specific cleavage is the conservation of W267 (W261 in ChikV)  and an intact catalytic triad . An exchange of threonine for serine (S262T) failed to prevent this cleavage, and showed that serine is not important for its activity. Deletion of 46 aa from C-terminus inactivated the protease either due to the missing stretch in the cleavage site or a major change in the tertiary structure. These results also showed that aa within the C-terminus of the ChikV capsid are important for the activity of the protease.
It has been shown before in the SFV capsid protease that only W267 at the cleavage site allowed efficient viral growth . Tryptophan is the preferred amino acid for cleavage as mutating tryptophan in position 261 to the hydrophobic alanine resulted in un-cleaved protein (Figure 2, lane 9).
In the crystal structure of SFV and Sindbis virus capsid W is anchored in the active site, but the C-terminal folding and stability is also dependent on aa 264 to 266, which form an antiparallel β-structure with aa 235 to 237 of the protein [4, 5]. Thus, it is possible that aa close to the cleavage site anchor the W to the active site. This prompted us to look for the importance of other aa near to tryptophan. Mutation of other conserved or less conserved residues (Figure 1) close to tryptophan did not alter the activity of the ChikV capsid protease (Figure 2). This further confirms that the prevention of cleavage when substituting tryptophan to alanine is because of an amino acid preference rather than a change in tertiary structure or improper folding, as proposed before .
As ChikV capsid encodes a serine protease, we checked if the serine protease inhibitor AEBSF would affect its activity. It was found that AEBSF didn't inhibit the activity even at high concentrations (Figure 3). AEBSF's mode of action is by covalently modifying serine residues in the active sites of proteases such as trypsin, chymotrypsin, plasmin, kallikrein and thrombin. It is also able to modify serine residues on other proteins adding an amine group and thereby, shifting the pI to higher values . Here, lack of inhibition may be a specific property of the alphavirus capsid protease, were it gets self-inactivated after the cleavage.
One mutant introduced by error-prone PCR resulted in complete loss of protease activity when isoleucine at position 227 was changed to lysine. Molecular modelling showed that the formation of a salt bridge between mutant K227 and D161 potentially affects crucial functions of D161 (Figure 4B). D161 is one out of three conserved aa, forming the autocatalytic triad of the capsid protease. The probable salt bridge between K227 and D161 obviously disrupts the protease activity of the autocatalytic triad. In the native enzyme, D161 makes a low barrier hydrogen bond (LBHB) with H139 . Due to this LBHB, H139 acts as general base and abstracts the proton from the S213 hydroxyl group. De-protonated S213 will act as a nucleophile and will form a tetrahedral transition state with carbonyl carbon of the substrate. The disruption of LBHB by N-methylation of histidine  or by mutation of D161 of the catalytic triad to asparagine has been shown to inactivate serine proteases . The potential salt bridge between D161 and mutant K227 may also disrupt the LBHB between D161 and H139 and may consequently make the enzyme inactive as the salt bridge can be very stable in the hydrophobic environment of the active site .
In conclusion, our analysis shows that tryptophan, but not the serine near the cleavage site is important for the ChikV protease activity. We also found that I227 is located close to the catalytic triad of the ChikV capsid and a mutation of this residue leads to disruption of the protease activity. Thus we are showing that aa other than the catalytic triads are important for the activity of this serine protease within the ChikV capsid.
Cloning and mutagenesis
Primers used to mutate the capsid protease of Chikungunya virus
Nucleotide sequence (5'-3')
(deletes aa 216-261)
atcccgggtcgc ctcttcggccc (4)
A258E (EGE EEW)
atcccgggtccactcttcttc cccctcgg (5)
A258 S (EGS EEW)
atcccgggtccactcttcgga cccctcgg (6)
E256A (A GAEEW)
A258T (EGT EEW)
atcccgggtccactcttcggt cccctcgg (8)
E260 D (EGAED W)
atcccgggtccaatc ttcggccc (9)
E260A (EGAEA W)
atcccgggtccacgc ttcggccc (10)
Serine 213 in the catalytic triad was mutated to alanine by fusion PCR  using primers [5'-atggactacaaagacgatgacgataagatggagttcatcccaac-3', 5'-aagatcggtctaccgg cgtcccctggttt-3'] and [5'-aaaccaggggacgcc ggtagaccgatctt-3', 5'-atcccgggtccactcttcggctc-3']. Error-prone PCR was performed using oligos FlagChik cap and ChikcapXmaI_WT (Table 1) as primers. Reaction mixtures contained 10× PCR buffer (Qiagen), 5 mM Mg2+, 10 ng of template DNA, 10 pM of each primer, and 2.5 U of Taq polymerase. The reaction conditions were as follows: step 1, 5 min, 95°C; step 2, 30 s, 94°C; step 3, 30 s, 58°C; step 4, 45 s, 72°C; and step 5, 7 min, 72°C; steps 2 to 4 were repeated 35 times.
Cell culture, transfection, and inhibition studies
HEK293 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), 100 U/ml penicillin, and 100 μg/ml streptomycin. For transfection, HEK293 cells were seeded in 12-well plates at a density of 2 × 105 cells and transfection was performed using turbofect (Fermentas) transfection reagent according to the manufacturer's instruction. For inhibition studies, serine protease inhibitor AEBSF (4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride); (Sigma-Aldrich) at a concentration from 100 μM to 1 M was used.
48 hours post transfection, cells were washed once with PBS followed by lysis using RIPA buffer (Sigma). Protein samples were subjected to 12% SDS-PAGE and transferred to PVDF membrane (Amersham) by using Xcell II blot module (Invitrogen) and blocked overnight at 4°C with 3% BSA in PBST. The membranes were probed with monoclonal anti-FLAG antibodies (Sigma) followed by anti-mouse secondary antibodies conjugated with horseradish peroxidase (Santacruz). Blots were visualized with the enhanced chemiluminescence (ECL) detection reagents (Amersham, UK).
Protein modelling and analysis
The structure of the capsid protease was modelled using automated homology modelling server 3D-JIGSAW http://bmm.cancerresearchuk.org/~3djigsaw/. The template, Semliki Forest virus capsid protein (PDB ID 1VCP) is 91% identical in sequence to the ChikV capsid protease domain, which makes the model more reliable. Comparison of WT and mutant structures were done using SPDBV software . The figures were generated using pymol http://www.pymol.org. Energy computations were done with the GROMOS90 implementation of Swiss-PdbViewer.
The authors thank Monika Radtke for the excellent technical assistance and Ottmar Herchenröder for critically reading the manuscript. Saijo Thomas was supported by a grant from DAAD.
- Jose J, Snyder JE, Kuhn RJ: A structural and functional perspective of alphavirus replication and assembly. Future Microbiol 2009, 4: 837-856. 10.2217/fmb.09.59PubMedPubMed CentralView ArticleGoogle Scholar
- Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, Sol-Foulon N, Le Roux K, Prevost MC, Fsihi H, Frenkiel MP, Blanchet F, Afonso PV, Ceccaldi PE, Ozden S, Gessain A, Schuffenecker I, Verhasselt B, Zamborlini A, Saib A, Rey FA, Arenzana-Seisdedos F, Despres P, Michault A, Albert ML, Schwartz O: Characterization of reemerging chikungunya virus. PLoS Pathog 2007, 3: e89. 10.1371/journal.ppat.0030089PubMedPubMed CentralView ArticleGoogle Scholar
- Cheng RH, Kuhn RJ, Olson NH, Rossmann MG, Choi HK, Smith TJ, Baker TS: Nucleocapsid and glycoprotein organization in an enveloped virus. Cell 1995, 80: 621-630. 10.1016/0092-8674(95)90516-2PubMedPubMed CentralView ArticleGoogle Scholar
- Choi HK, Lee S, Zhang YP, McKinney BR, Wengler G, Rossmann MG, Kuhn RJ: Structural analysis of Sindbis virus capsid mutants involving assembly and catalysis. J Mol Biol 1996, 262: 151-167. 10.1006/jmbi.1996.0505PubMedView ArticleGoogle Scholar
- Choi HK, Lu G, Lee S, Wengler G, Rossmann MG: Structure of Semliki Forest virus core protein. Proteins 1997, 27: 345-359. 10.1002/(SICI)1097-0134(199703)27:3<345::AID-PROT3>3.0.CO;2-CPubMedView ArticleGoogle Scholar
- Owen KE, Kuhn RJ: Alphavirus budding is dependent on the interaction between the nucleocapsid and hydrophobic amino acids on the cytoplasmic domain of the E2 envelope glycoprotein. Virology 1997, 230: 187-196. 10.1006/viro.1997.8480PubMedView ArticleGoogle Scholar
- Melancon P, Garoff H: Processing of the Semliki Forest virus structural polyprotein: role of the capsid protease. J Virol 1987, 61: 1301-1309.PubMedPubMed CentralGoogle Scholar
- Skoging U, Liljestrom P: Role of the C-terminal tryptophan residue for the structure-function of the alphavirus capsid protein. J Mol Biol 1998, 279: 865-872. 10.1006/jmbi.1998.1817PubMedView ArticleGoogle Scholar
- Morillas M, Eberl H, Allain FH, Glockshuber R, Kuennemann E: Novel enzymatic activity derived from the Semliki Forest virus capsid protein. J Mol Biol 2008, 376: 721-735. 10.1016/j.jmb.2007.11.055PubMedView ArticleGoogle Scholar
- Sweeney B, Proudfoot K, Parton AH, King LM, Slocombe P, Perry MJ: Purification of the T-cell receptor zeta-chain: covalent modification by 4-(2-aminoethyl)-benzenesulfonyl fluoride. Anal Biochem 1997, 245: 107-109. 10.1006/abio.1996.9942PubMedView ArticleGoogle Scholar
- Frey PA, Whitt SA, Tobin JB: A low-barrier hydrogen bond in the catalytic triad of serine proteases. Science 1994, 264: 1927-1930. 10.1126/science.7661899PubMedView ArticleGoogle Scholar
- Henderson R: Catalytic activity of - chymotrypsin in which histidine-57 has been methylated. Biochem J 1971, 124: 13-18.PubMedPubMed CentralView ArticleGoogle Scholar
- Craik CS, Roczniak S, Largman C, Rutter WJ: The catalytic role of the active site aspartic acid in serine proteases. Science 1987, 237: 909-913. 10.1126/science.3303334PubMedView ArticleGoogle Scholar
- Anderson DE, Becktel WJ, Dahlquist FW: pH-induced denaturation of proteins: a single salt bridge contributes3–5kcal/mol to the free energy of folding of T4 lysozyme. Biochemistry 1990, 29: 2403-2408. 10.1021/bi00461a025PubMedView ArticleGoogle Scholar
- Kowalzik S, Xuan NV, Weissbrich B, Scheiner B, Schied T, Drosten C, Müller A, Stich A, Rethwilm A, Bodem J: Characterisation of a chikungunya virus from a German patient returning from Mauritius and development of a serological test. Med Microbiol Immunol 2008, 197: 381-386. 10.1007/s00430-008-0090-5PubMedView ArticleGoogle Scholar
- Szewczyk E, Nayak T, Oakley CE, Edgerton H, Xiong Y, Taheri-Talesh N, Osmani SA, Oakley BR: Fusion PCR and gene targeting in Aspergillus nidulans. Nat Protoc 2006, 1: 3111-3120. 10.1038/nprot.2006.405PubMedView ArticleGoogle Scholar
- Offman MN, Tournier AL, Bates PA: Alternating evolutionary pressure in a genetic algorithm facilitates protein model selection. BMC Struct Biol 2008, 8: 34. 10.1186/1472-6807-8-34PubMedPubMed CentralView ArticleGoogle Scholar
- Guex N, Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18: 2714-2723. 10.1002/elps.1150181505PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.